Skip to content

Public FDA record

Z-2574-2026: Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 US Retail Sensor/Trans

Recall record Z-2574-2026 for Dexcom, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2574-2026
Company in FDA record
Dexcom, Inc.
FDA classification date
Jun 24, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process. The sensors were later sold to pharmacies and distributors by Pharmsource, LLC. Lot 1725204004 were designated for destruction because the G7 sensors were not properly sterilized and have an increased risk of skin infection if used. Lot 1725069002 were designated for destruction due to an increased risk of having no sensor readings available or experiencing sensor inaccuracy that includes the potential for missed detection of a hyperglycemic event or incorrect treatment decisions that can result in patient injury, including medical intervention to prevent permanent injury or impairment. Additionally, due to the unknown storage and handling and storage conditions these sensors may have undergone during the distribution, these sensors may present additional risk.

Source facts

Action
On 05/26-27/2026, the firm issued a Press Release and sent an "URGENT: MEDICAL DEVICE CORRECTION NOTIFICATION" informing customers and the public that Dexcom is aware that two lots (1725204004 and 1725069002) of Dexcom G7 sensors, originally designated as scrap and intended for destruction, were stolen and distributed. For Patients/Healthcare Providers: 1. Check lot number on G7 sensor outer box and compare with the listed lot numbers in this notification. If the lot number is listed, the device is affected. If affected, skip to step 3 below to document affected serial number(s). 2. Determine if current or unused sensor(s) is affected based on serial number by visiting www.dexcom.com/theft-check and enter serial number into the serial number look-up. Reference https://www.dexcom.com/faqs/how-to-find-dexcom-g7-serial-number for instructions. 3. If you have affected product(s), immediately discontinue use and dispose of them. Contact Dexcom Technical Support at 1-844-478-1600 with questions or to request a no-cost replacement. Important: Keep record of affected serial number for traceability purposes This is required to confirm no cost replacement. 4. Replace the affected sensor with an unaffected sensor for glucose monitoring. If you do not have an unaffected G7 sensor, use a blood glucose meter for treatment decisions until you receive a replacement sensor. 5. Contact healthcare provider if you have symptoms of infection or inflammation redness, swelling, or pain at the insertion site. Independent Pharmacies: Check inventory if purchased G7 sensors from Pharmsource, LLC. If you have product from the lots listed, immediately dispose of the product. Contact Dexcom with any related inquiries at inquiries@dexcom.com.
Initiated
2026-05-27
Root cause
Nonconforming Material/Component
Distribution
Dexcom does not have distribution records for this product due to its unauthorized release. However Dexcom is able to identify sensor session starts for the affected lots through the Dexcom G7 CGM App user performance data. Based on App user performance data, Lot 1725204004 has sensor session starts in the United States. Based on App user performance data, Lot 1725069002 has sensor session starts in the United States and the countries of Australia, Austria, Canada, Czech Republic, Finland, France, Germany, Hong Kong, Israel, Italy, Japan, South Korea, Kuwait, Netherlands, Poland, Portugal, Qatar, Singapore, Spain, Switzerland, Turkey, United Arab Emirates,and the United Kingdom.
Recall number
Z-2574-2026
Recall status
Open, Classified
CDRH record ID
220303
FDA classified
2026-06-24
Recall event number
98968

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗